Maryanne Demasi, reports β’ 2692 implied HN points β’ 22 Jan 24
- A former TGA boss has been appointed to the board of Medicines Australia to advance mRNA technology in Australia.
- John Skerritt, previously with TGA, reflects on his achievements in speeding up drug approvals during his time there.
- Concerns are raised about the 'revolving door' practice where agency officials end up working for industries they once regulated.